Ulcerative Colitis

Clinical Trials

Below is a list of Ulcerative Colitis clinical trials from the clinical trials database at Mayo Clinic.

This list includes only trials about which Mayo researchers choose to publish information. Mayo Clinic may be conducting other trials which are not in this database. Mayo's clinical trials include experimental treatments, often unavailable elsewhere, which frequently lead to improved patient care for people worldwide. Patients should ask their doctor at Mayo about clinical trials appropriate for their situation.

A Phase I Study Using rhuMAb Beta7 for Patients with Ulcerative Colitis
The purpose of this study is to investigate the safety and tolerability of an investigational drug called rhuMAb Beta7 in the treatment of ulcerative colotis (UC) at different dose levels and different routes of administration. The sponsor of the trial is developing rhuMAb Beta7 as a possible treatment to reduce the symptoms associated with UC and Crohn's disease, another inflammatory bowel condition.
Read more

Golimumab therapy, administered subcutaneously, for patients ulcerative colitis
The main purpose of this study is to assess the effects (good and bad) of golimumab on subjects with ulcerative colitis.
Read more